PARIS, Dec. 2, 2024 /PRNewswire/ -- As from November 2024, Heuritech has officially joined the Luxurynsight Group. This strategic operation marks…
PARIS, Dec. 2, 2024 /PRNewswire/ -- As from November 2024, Heuritech has officially joined the Luxurynsight Group. This strategic operation marks…
First-of-its-kind environmental initiative addresses the critical data shortage for MEP products needed to decarbonize building services.RUEIL-MALMAISON, France, Nov. 28, 2024 /PRNewswire/…
Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC.Updated results of…
Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC.Updated results of…
Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC.Updated results of…
MINNEAPOLIS, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Atomic Data today announced a multi-year agreement to make it the Official IT…
-- Achieved all co-primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies versus each…
November 18, 2024 11:15 ET | Source: BridgeBio Pharma, Inc. - Acoramidis demonstrated the earliest known time to separation in…
SAN FRANCISCO, Nov. 17, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted…
